C
Chemelion creates nanoscale robotic platforms that navigate biological environments to deliver drugs, perform targeted tissue repair, and collect real-time biomarker data. The technology enables minimally invasive therapeutic and diagnostic procedures, and the company licenses these solutions to pharmaceutical and healthcare partners.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Chemelion develops nanoscale robotic platforms designed for therapeutic and diagnostic applications in medicine. Their nano‑robots can be programmed to navigate biological environments, deliver drugs, perform targeted tissue repair, or collect real‑time biomarker data, enabling minimally invasive treatment and precision health monitoring. The company commercializes these solutions through partnerships with pharmaceutical firms and healthcare providers, generating revenue via product licensing, per‑use fees, and customized integration services.